Onconetix, Inc.
ONCO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $304 | $106 | $102 | $712 |
| % Growth | 185.1% | 4.8% | -85.7% | – |
| Cost of Goods Sold | $35 | $36 | $56 | $52 |
| Gross Profit | $269 | $71 | $46 | $660 |
| % Margin | 88.6% | 66.2% | 45.1% | 92.7% |
| R&D Expenses | -$3 | -$112 | $24 | -$0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,341 | $1,524 | $1,674 | $2,663 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $594 | $10,918 | $27,143 |
| Operating Expenses | $2,338 | $2,006 | $12,617 | $29,806 |
| Operating Income | -$2,069 | -$1,935 | -$12,571 | -$29,146 |
| % Margin | -681.5% | -1,817.4% | -12,369.2% | -4,093.7% |
| Other Income/Exp. Net | -$6,714 | -$437 | $4,025 | -$1,210 |
| Pre-Tax Income | -$8,784 | -$2,372 | -$8,546 | -$30,356 |
| Tax Expense | $0 | $0 | $0 | -$918 |
| Net Income | -$8,784 | -$2,372 | -$8,546 | -$29,438 |
| % Margin | -2,892.7% | -2,227.8% | -8,408.8% | -4,134.7% |
| EPS | -6.25 | -4.76 | -1,802 | -17.38 |
| % Growth | -31.3% | 99.7% | -10,268.2% | – |
| EPS Diluted | -6.25 | -4.76 | -1,802 | -17.38 |
| Weighted Avg Shares Out | 1,405 | 568 | 214 | 138 |
| Weighted Avg Shares Out Dil | 1,405 | 568 | 214 | 138 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $300 | $223 | $224 | $248 |
| Depreciation & Amortization | $3 | $4 | $5 | $119 |
| EBITDA | -$8,480 | -$2,146 | -$8,318 | -$29,989 |
| % Margin | -2,792.8% | -2,014.8% | -8,184.1% | -4,212% |